all 214504 studies found for:    ALL
Show Display Options
Rank Status Study
1 Recruiting Self-Guided Online Cognitive Behavioral Strategies for Chemotherapy-Induced Peripheral Neuropathy
Conditions: Peripheral Nervous System Diseases;   Pain Management;   Self Management
Intervention: Device: Proactive Self Management Program for Effects of Cancer Treatment
2 Recruiting Egg Diet to Improve Metabolic Health and Function
Condition: Obesity
Interventions: Other: Egg-based diet (EBD);   Other: Carbohydrate-based diet (CBD)
3 Not yet recruiting The First Twenty (TF20) for Volunteer Firefighters in a Clinic Based Setting
Condition: Obesity
Intervention: Behavioral: The First Twenty (TF20)
4 Not yet recruiting Phase 4, Vedolizumab-4002 Post-marketing, Disease-Drug-Drug Interaction Study
Conditions: Colitis, Ulcerative;   Crohn Disease
Interventions: Drug: Caffeine;   Drug: Losartan;   Drug: Omeprazole;   Drug: Dextromethorphan;   Drug: Midazolam;   Drug: Vedolizumab
5 Not yet recruiting A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Solanezumab;   Drug: Placebo
6 Recruiting Magnetic Resonance Imaging and Functional Performance Outcome After ACL Repair With Internal Brace Technique
Condition: Anterior Cruciate Ligament Tear
Intervention:
7 Completed 18612 - Sun Protection Factor Assay
Condition: Sunscreening Agents
Intervention: Drug: BAY 987521
8 Completed 18611 - Sun Protection Factor Assay
Condition: Sunscreening Agents
Intervention: Drug: BAY 987517
9 Completed Policy-Related Survey - Territory-wide Telephone Survey on Tobacco Control
Condition: Tobacco Use
Intervention: Other: No intervention
10 Completed Lay Health Worker Model to Reduce Liver Cancer Disparities in Asian Americans
Conditions: Liver Neoplasms;   Hepatitis B
Interventions: Behavioral: Lay Health Worker Intervention;   Behavioral: Placebo (a list of resources)
11 Active, not recruiting Desensitizing Distressing Recollections in Cancer Patients
Condition: Cancer
Intervention: Behavioral: NET Intervention
12 Recruiting Anthocyanin Dose-escalation Study in Healthy Young Adults
Condition: Healthy
Interventions: Dietary Supplement: Anthocyanin;   Dietary Supplement: Placebo
13 Recruiting Study of REGN2810 in Patients With Advanced Cutaneous Squamous Cell Carcinoma
Condition: Advanced Cutaneous Squamous Cell Carcinoma
Intervention: Drug: REGN2810
14 Not yet recruiting A Study of INCB039110 in Combination With Ibrutinib in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Condition: Diffuse Large B-cell Lymphoma
Interventions: Drug: INCB039110;   Drug: ibrutinib
15 Completed A Fatty Acids Study in Preventing Retinopathy of Prematurity
Condition: Retinopathy of Prematurity
Interventions: Drug: SMOFlipid;   Drug: Clinoleic
16 Not yet recruiting Effects of Perioperative Intravenous Dexamethasone on the Severity of Persistent Postsurgical Pain After Total Knee Arthroplasty : A Prospective, Randomized, Double-blind, Placebo-controlled Trial
Condition: Effects of Perioperative Intravenous Dexamethasone on the Severity of Persistent Postsurgical Pain After Total Knee Arthroplasty
Interventions: Drug: Dexamethasone;   Drug: Normal saline solution
17 Recruiting Translation and Validation of the French Version of Confusion Assessment Method for the Intensive Care Unit
Condition: Patients With Mental Confusion
Intervention: Behavioral: CAM-ICU.fr
18 Not yet recruiting Evaluation of the Effectiveness and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking an Existing Medication Called a Tumour Necrosis Factor Alpha Inhibitor But Have Active Disease
Condition: Rheumatoid Arthritis
Interventions: Drug: Olokizumab q4w;   Drug: Olokizumab q2w;   Drug: Placebo q2w
19 Not yet recruiting 3 Days Amoxicillin Versus Placebo for Fast Breathing Childhood Pneumonia in Malawi
Condition: Pneumonia
Interventions: Drug: Amoxicillin;   Drug: Placebo
20 Not yet recruiting Evaluation of the Effectiveness and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease
Condition: Rheumatoid Arthritis
Interventions: Drug: Olokizumab 64 mg q4w + Methotrexate;   Drug: Olokizumab 64 mg q2w + Methotrexate;   Drug: Adalimumab 40 mg q2w + Methotrexate;   Drug: Placebo q2w + Methotrexate

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years